Skip to main content
. 2019 Nov 15;11(11):971–982. doi: 10.4251/wjgo.v11.i11.971

Table 1.

Clinical, pathological and molecular features of colorectal carcinomas according to CNN3 expression status

Clinical and pathological features Total CNN3 expression
P value
Negative, n (%) Positive, n (%)
All cases 57 37 (65) 20 (35)
Gender male 32 21 (56) 11 (34) NS
female 25 16 (64) 9 (36)
Age in yr ≤ 50 35 23 (66) 12 (34) NS
> 50 22 14 (64) 8 (36)
Histological variant adenocarcinoma 44 27 (61) 17 (39) NS
mucinous adenocarcinoma 9 8 (89) 1 (11)
others1 4 2 (50) 2 (50)
Differentiation/grade2 well/moderate 18 12 (67) 6 (33) NS
poor 33 22 (67) 11 (33)
Stage2 early (I and II) 32 20 (63.5) 12 (37.5) NS
late (III and IV) 23 15 (65) 8 (35)
Extracellular mucin present 21 13 (62) 8 (38) NS
absent 36 24 (67) 12 (33)
MSI status2 MSI 15 8 (53) 7 (47) NS
MSS 38 25 (66) 13 (34)
p53 negative 28 19 (68) 9 (32) NS
stabilized 29 18 (62) 11 (38)
1

Other subtypes were: 1 medullary carcinoma, 1 squamous cell carcinoma [both were negative for Calponin 3 (CNN3)], 1 signet ring carcinoma, and 1 undifferentiated carcinoma (both were positive for CNN3);

2

Variation in total numbers were due to unavailable data. Extracellular mucin was detected morphologically after staining with hematoxylin and eosin as well as Periodic Acid-Schiff. Microsatellite instability was detected by the microsatellite markers BAT25 and BAT26; p53 status was characterized by immunohistochemical detection of protein stabilization[21,22]. NS: Not significant; MSI: Microsatellite instability; MSS: Microsatellite stable; CNN3: Calponin 3.